The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce ...
The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs. The move is part of a Trump administration program aimed at prioritizing medicines that ...
Fast Track Designation underscores the promise of Werewolf’s INDUKINE™ platform WATERTOWN, Mass., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback